Human immunodeficiency virus contains an epitope immunoreactive with thymosin alpha 1 and the 30-amino acid synthetic p17 group-specific antigen peptide HGP-30.

Human immunodeficiency virus contains an epitope immunoreactive with thymosin alpha 1 and the 30-amino acid synthetic p17 group-specific antigen peptide HGP-30.

Item
http://www.wikidata.org/entity/Q34619693
Pathogenesis of human immunodeficiency virus infectionHGP-30, a synthetic analogue of human immunodeficiency virus (HIV) p17, is a target for cytotoxic lymphocytes in HIV-infected individuals.Functional anatomy of the thymic microenvironment.HIV-1 matrix protein p17 increases the production of proinflammatory cytokines and counteracts IL-4 activity by binding to a cellular receptor.The thymus in acquired immune deficiency syndrome. Comparison with other types of immunodeficiency diseases, and presence of components of human immunodeficiency virus type 1Alterations of thymus cortical epithelium and interdigitating dendritic cells but no increase of thymocyte cell death in the early course of simian immunodeficiency virus infection.Characterization of human immunodeficiency virus type 1 p17 matrix protein motifs associated with mother-to-child transmission.Protection against Friend retrovirus-induced leukemia by recombinant vaccinia viruses expressing the gag gene.Peptide component vaccine engineering: targeting the AIDS virus.Human immunodeficiency virus type 1-neutralizing monoclonal antibodies which react with p17 core protein: characterization and epitope mapping.Characterization of monoclonal antibodies against the human immunodeficiency virus matrix protein, p17gag: identification of epitopes exposed at the surfaces of infected cells.A neutralizing monoclonal antibody previously mapped exclusively on human immunodeficiency virus type 1 gp41 recognizes an epitope in p17 sharing the core sequence IEEE.Relation between humoral responses to HIV gag and env proteins at seroconversion and clinical outcome of HIV infection.A prospective study on correlation between the decrease in anti-P17 antibody level and progression to AIDS in asymptomatic carriers of HIV.Molecular immunopathogenesis of HIV infection.Identification of a potent synthetic HIV1 immunogen compromising gag-P24 tandem T- and B-cell epitopes.Overproduction, purification, and diagnostic use of the recombinant HIV-1 Gag proteins, the precursor protein p55 and the processed products p17, p24, and p15.
P2860

Human immunodeficiency virus contains an epitope immunoreactive with thymosin alpha 1 and the 30-amino acid synthetic p17 group-specific antigen peptide HGP-30.

Item
http://www.wikidata.org/entity/Q34619693
description
1987 nî lūn-bûn
@nan
1987 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
Human immunodeficiency virus c ...... ecific antigen peptide HGP-30.
@ast
Human immunodeficiency virus c ...... ecific antigen peptide HGP-30.
@en
Human immunodeficiency virus c ...... ecific antigen peptide HGP-30.
@nl
type
label
Human immunodeficiency virus c ...... ecific antigen peptide HGP-30.
@ast
Human immunodeficiency virus c ...... ecific antigen peptide HGP-30.
@en
Human immunodeficiency virus c ...... ecific antigen peptide HGP-30.
@nl
prefLabel
Human immunodeficiency virus c ...... ecific antigen peptide HGP-30.
@ast
Human immunodeficiency virus c ...... ecific antigen peptide HGP-30.
@en
Human immunodeficiency virus c ...... ecific antigen peptide HGP-30.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P932
P356
P1433
P1476
Human immunodeficiency virus c ...... ecific antigen peptide HGP-30.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P932